Pardes Biosciences Inc
Biotechnology
Healthcare
PRDS
60.21 M shares
NASDAQ US
traded
30 Aug 2023
listed
yes
open
2.16
52 week high
5.78
high
2.20
52 week low
1.32
previous Close
2.16
P/E ratio
market cap
130 M
div yield
0
net incoming
-10.78 M
23.96 %
net profit margin
-1077500000.00 %
0.00 %
operating incoming
-10.78 M
49.78 %
net change in cash
53.10 M
538.14 %
cash on hand
100.27 M
112.59 %
top